Which outcome is associated with COX-2 inhibition?

Prepare for the Dermatology Week 1 Exam with comprehensive study materials. Practice with detailed questions, flashcards, and expert explanations. Boost your knowledge and confidence for the exam!

Multiple Choice

Which outcome is associated with COX-2 inhibition?

Explanation:
COX-2 is the inducible enzyme that drives the production of inflammatory prostaglandins, such as PGE2, which promote pain, swelling, and redness. When COX-2 is inhibited, these inflammatory mediators decrease, leading to reduced inflammation and symptom relief. This is why COX-2 inhibitors are effective anti-inflammatory agents. In contrast, COX-1 supports gastric mucosal protection and platelet function, so inhibiting COX-2 spares these functions and typically results in less gastric irritation than nonselective NSAIDs. Thus, the outcome most associated with COX-2 inhibition is a reduction in inflammation.

COX-2 is the inducible enzyme that drives the production of inflammatory prostaglandins, such as PGE2, which promote pain, swelling, and redness. When COX-2 is inhibited, these inflammatory mediators decrease, leading to reduced inflammation and symptom relief. This is why COX-2 inhibitors are effective anti-inflammatory agents. In contrast, COX-1 supports gastric mucosal protection and platelet function, so inhibiting COX-2 spares these functions and typically results in less gastric irritation than nonselective NSAIDs. Thus, the outcome most associated with COX-2 inhibition is a reduction in inflammation.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy